Study of Circulating Blood Cell Monocytes as Predictive Biomarker of Bone Cystic Fibrosis Disease. Impact of CFTR Correctors.
NCT03492567
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Interventions
BIOLOGICAL:
Blood test
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
[object Object]
[object Object]